The Ophthalmic Surgical Devices Market Report is Segmented by Product (Refractive Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Other Surgical Devices), End-User (Hospitals, Specialty Ophthalmic Clinics, Ambulatory Surgery Centers (ASCs), and Other End-Users), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

The cataract surgery device market has exhibited an ascending trend, where its value is estimated to go from US$ 8,928 million in 2024 to US$ 12,472.70 million in 2034. Adoption of cataract surgery devices is exhibiting a growth rate of 3.40% from 2024 to 2034.

Attributes	Details
Cataract Surgery Device Market Value for 2024	US$ 8,928 million
Cataract Surgery Device Market Value for 2034	US$ 12,472.70 million
Cataract Surgery Device Market Forecast CAGR for 2024 to 2034	3.40%

Historical Performance and Future Growth of the Cataract Surgery Device Market

Historical CAGR (2019 to 2023)	2.70%
Forecast CAGR (2024 to 2034)	3.40%

Category-wise Insights

Segment	Estimated Market Share in 2024
Intraocular lens (IOL)	46.80%
Nuclear Sclerotic Cataract	38.40%

Key Countries in the Cataract Surgery Device Sector

Country	United States
CAGR till 2034	1.50%

Country	United Kingdom
CAGR till 2034	2.30%

Country	Germany
CAGR till 2034	2.90%

Country	India
CAGR till 2034	4.90%

Country	Thailand
CAGR till 2034	3.70%

Snapshot img

Ophthalmology Surgical Devices Market Size 2024-2028

The ophthalmology surgical devices market size is forecast to increase by USD 2.81 billion at a CAGR of 5.21% between 2023 and 2028.

The market is witnessing significant growth due to the increasing prevalence of ophthalmic diseases. According to the National Eye Institute, around 285 million people worldwide are estimated to be visually impaired, with 80% of cases attributable to preventable causes. This trend is driving the demand for advanced surgical devices to address various eye conditions. Strategic collaborations and mergers and acquisitions among market companies are also contributing to market growth. However, high costs and limited reimbursements pose challenges to the market expansion. Despite these hurdles, the market is expected to continue its upward trajectory due to the unmet medical needs and technological advancements In the field of ophthalmology.

What will be the Size of the Ophthalmology Surgical Devices Market During the Forecast Period?

Request Free SampleThe market encompasses a range of advanced technologies designed to address various eye disorders, including cataracts, glaucoma, and diabetic retinopathy. Key market drivers include the growing prevalence of ophthalmic disorders, particularly among the geriatric population, and the increasing demand for minimally invasive surgical procedures. Cataract surgeries, which involve the implantation of intraocular lenses, remain a significant segment of the market due to the high incidence of advanced cataracts and the resulting symptoms such as blurred vision, glare, and visual changes. Microscopes and robotic technologies are also gaining traction, enabling more precise and efficient ophthalmic surgeries. The backlog of patients seeking consultations for ocular disorders continues to fuel market growth.Symptoms like eye redness, refractive errors, and symptoms related to diabetes and other conditions further expand the market scope. Laser surgery and the development of advanced artificial lenses continue to shape the market landscape.

How is this Ophthalmology Surgical Devices Industry segmented and which is the largest segment?

The ophthalmology surgical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductCataract surgery devicesGlaucoma surgery devicesRefractive surgery devicesVitreoretinal surgery devicesGeographyNorth AmericaUSEuropeGermanyUKAsiaChinaJapanRest of World (ROW)

By Product Insights

The cataract surgery devices segment is estimated to witness significant growth during the forecast period.

Ophthalmology surgical devices play a crucial role in addressing various eye disorders, including cataracts and glaucoma. Cataracts, a leading cause of vision impairment, affect individuals due to aging or eye injuries, and are associated with symptoms such as blurred vision, difficulty reading, and visual changes. According to the National Eye Institute, over 24.4 million Americans aged 40 and above have cataracts. Glaucoma, another prevalent ophthalmic disorder, affects over 3 million Americans and results in severe visual impairment or blindness if left untreated. Advanced technologies like microscopes, robotic technologies, and laser technology are transforming ophthalmic surgeries, including cataract surgeries utilizing phacoemulsification systems and intraocular lenses.Technological advancements, such as SmartCataract solutions and the Hydrus Microstent for glaucoma, offer innovative alternatives for managing ophthalmic disorders. The geriatric population, with its increasing prevalence of cataracts and glaucoma, drives the demand for these surgical devices. The ophthalmic equipment market encompasses a wide range of surgical products, including vitreoretinal surgery devices, ophthalmology drugs, and glaucoma surgical devices. The aging population and the increasing prevalence of eye disorders, such as cataract, diabetic retinopathy, and macular degeneration, necessitate advancements in ophthalmic equipment.

Get a glance at the Ophthalmology Surgical Devices Industry report of share of various segments Request Free Sample

The Cataract surgery devices segment was valued at USD 3.4 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American the market is experiencing significant growth due to increasing healt

The Cataract Surgery Devices Market Report Segments the Industry Into by Product Type (Intraocular Lenses, Femtosecond Laser Systems, and More), by Surgery Technique (Phaco-Based Standard Surgery and More), by End User (Hospitals, Ambulatory Surgery Centers, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

The global ophthalmic surgical market is expected to grow at a CAGR of 5.7% from 2024 to 2034. The market value is projected to increase from US$ 13,937.8 million in 2024 to US$ 24,194.2 million by 2034.

Attributes	Key Insights
Base Value, 2023	US$ 13,159.7 million
Estimated Global Ophthalmic Surgical Market Size (2024E)	US$ 13,937.8 million
Projected Ophthalmic Surgical Market Value (2034F)	US$ 24,194.2 million
Value-based CAGR (2024 to 2034)	5.7%

Country-wise Insights

Country	Value CAGR
United States	8.3%
Japan	8.1%
China	7.1%
Germany	7.7%
United Kingdom	7.3%

Category-wise Insights

Segment	Value CAGR
Consumable (Product Type)	5.3%
Ophthalmic Clinics (Distribution Channel)	5.3%

The global ophthalmology surgical devices market, valued at $9.72 billion in 2025, is projected to experience robust growth, driven by several key factors. Rising prevalence of age-related eye diseases like cataracts and glaucoma, coupled with an aging global population, significantly fuels demand for advanced surgical solutions. Technological advancements, such as minimally invasive techniques, laser-assisted surgeries, and the development of sophisticated imaging systems, contribute to improved surgical outcomes and patient experience, further boosting market expansion. Increasing disposable incomes in emerging economies are also driving accessibility to these advanced procedures, particularly in regions like Asia-Pacific. The market is segmented into cataract, glaucoma, refractive, and vitreoretinal surgery devices, each experiencing varying growth rates based on technological innovations and disease prevalence. Competitive dynamics are shaped by the presence of established multinational corporations alongside innovative smaller players focused on niche technologies. The market's future growth will be influenced by ongoing research and development in areas such as artificial intelligence-assisted surgery and personalized medicine, creating opportunities for innovation and expansion. The competitive landscape is characterized by both large multinational corporations and smaller, specialized companies. Key players are engaged in strategic initiatives, including mergers and acquisitions, partnerships, and product development, to strengthen their market positions and expand their product portfolios. Regulatory approvals, reimbursement policies, and intellectual property rights are crucial factors influencing market growth. The market faces challenges such as high device costs, potential complications associated with surgery, and the need for skilled surgical personnel. Despite these challenges, the long-term outlook for the ophthalmology surgical devices market remains positive, driven by the persistent demand for effective solutions to address the increasing burden of vision impairment globally. Continued investment in research and development, coupled with expanding access to healthcare, are expected to further fuel market expansion throughout the forecast period (2025-2033).

The Japan Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Ophthalmology Devices Market Size 2024-2028

The ophthalmology devices market size is forecast to increase by USD 19.1 billion at a CAGR of 4.31% between 2023 and 2028.

The market is witnessing significant growth due to several key trends. The increasing prevalence of ophthalmic diseases is a major driver for market growth. According to the World Health Organization, approximately 217 million people worldwide are affected by blindness or low vision. Moreover, the rising number of medical tourism cases for affordable ophthalmology surgeries in developing countries is also boosting the market growth. Advancements in technology have led to the development of cutting-edge devices such as artificial intelligence (AI) in ophthalmology, fundus cameras, OCT scanners, and phacoemulsification machines. However, high costs and limited reimbursement for ophthalmic treatments pose a challenge to market growth. Despite these challenges, the market is expected to witness steady growth due to the development of advanced technologies and increasing government initiatives to improve healthcare infrastructure. The market trends and analysis report provides a comprehensive overview of these factors and more, offering valuable insights for stakeholders in the ophthalmology devices industry.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses a broad range of innovative technologies designed to address various optical disorders and surgical needs. This market includes devices for refractive surgery, such as LASIK and photorefractive keratectomy (PRK), which correct vision impairments caused by refractive defects. Additionally, retinal surgery devices are essential for treating conditions like diabetic retinopathy, vitreoretinal disorders, and glaucoma. Phacoemulsification devices and premium intraocular lenses (IOLs) are integral components of cataract operations. Phacoemulsification is a minimally invasive procedure that uses ultrasonic energy to fragment and remove cataract-affected lenses, while premium IOLs offer improved visual acuity and functionality. UV screens and refurbished equipment play a crucial role in the ophthalmic medical device market, ensuring the protection of the eyes from harmful radiation and extending the life cycle of surgical instruments.



Ophthalmic surgical instruments and diagnostic instruments cater to the needs of various ophthalmic procedures, from cataract operations to strabismus correction. The geriatric population represents a significant portion of the market, as age-related conditions like cataracts, glaucoma, and diabetic retinopathy are common among older adults. Binocular vision disorders and refractive defects are also prevalent, necessitating the continuous development and refinement of ophthalmic medical devices. Lasers and phacoemulsification machines are essential tools in the ophthalmic medical device market, enabling precise and efficient surgical procedures. The ongoing advancements in technology lead to improved patient outcomes and expanded treatment options. In summary, the ophthalmic medical device market is a dynamic and evolving sector, driven by the need to address various optical disorders and surgical requirements. The development and refinement of technologies, such as phacoemulsification devices, premium IOLs, lasers, and surgical instruments, are essential in meeting the demands of healthcare professionals and patients alike.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Vision care
  Ophthalmology surgical devices
  Ophthalmology diagnostic devices


End-user

  Hospitals and eye clinics
  Academic and research laboratories
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Product Insights

The vision care segment is estimated to grow significantly during the forecast period.

The market encompasses a range of products used in the diagnosis, treatment, and management of various eye conditions. These devices include diagnostic instruments, such as slit lamps, fundus cameras, and optical coherence tomography (OCT) machines, which aid in the detection and monitoring of diseases like CMV retinitis, diabetic retinopathy, and diabetic macular edema.

Additionally, the market includes corrective eyewear, such as contact lenses and spectacle lenses, with the latter being the most commonly used form of eyewear for correcting refractive errors. Plastic spectacle lenses, in particular, have gained popularity due to their advantages, including lightweight, break resistance, and su

The United Kingdom Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

[182] Ophthalmology Diagnostics and Surgical Devices Market to reach US$ 67,449.1 Mn by 2027. Market Analysis By Type, Region, and Key Players.

The global ophthalmic surgery devices market size was valued at USD 22.6 billion in 2022 and is projected to expand at a CAGR of 6.3% from 2023 to 2030, reaching USD 37.3 billion by 2030. The market growth is attributed to the rising prevalence of ophthalmic disorders, technological advancements, increasing demand for minimally invasive procedures, and growing awareness about eye care. The rising prevalence of ophthalmic disorders, such as cataracts, glaucoma, and macular degeneration, has fueled the demand for ophthalmic surgery devices. Technological advancements, such as the development of laser-assisted surgery systems, intraocular lenses, and advanced surgical instruments, have improved the precision and safety of ophthalmic surgeries. Additionally, the growing preference for minimally invasive procedures, such as laser eye surgery and vitreoretinal surgery, has contributed to the market growth. The increasing awareness about eye care, coupled with government initiatives and insurance coverage, has also played a key role in driving the market.

BCC Research Market Analyst says global market for ophthalmic devices diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028 at a CAGR of 6.3%.

The United States Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

Ophthalmology Cataract Surgery Devices Market Outlook

The ophthalmology cataract surgery devices market size was valued at approximately USD 8 billion in 2023 and is projected to reach around USD 14.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 7%. This growth is primarily driven by the increasing prevalence of cataracts, advancements in surgical technologies, and the rising demand for minimally invasive procedures. The aging population, which is more prone to cataract formation, further accelerates the market growth as healthcare systems globally are focusing on improving ophthalmic care and infrastructure.

One of the major growth factors in the ophthalmology cataract surgery devices market is the increasing global prevalence of cataracts. As the global population ages, there is a corresponding rise in the incidence of cataracts, which has become one of the leading causes of vision impairment worldwide. This demographic trend is significantly boosting the demand for cataract surgeries, consequently driving the need for advanced surgical devices. Additionally, public awareness campaigns and initiatives by various governments to reduce the burden of cataracts through subsidized surgical programs further propel market growth. The strategic involvement of non-profit organizations in providing cataract surgeries in developing regions is also playing a crucial role in expanding the market.

Technological advancements in cataract surgery devices are another key growth driver in this market. Innovations such as the development of femtosecond laser technology, advanced intraocular lenses (IOLs), and phacoemulsification devices have revolutionized the way cataract surgeries are performed. These technologies offer improved outcomes, reduced surgery time, and enhanced patient comfort, making them increasingly popular among ophthalmologists. The integration of digital and robotic technologies into surgical procedures is paving the way for more precise and minimally invasive operations, thereby attracting a larger patient base and increasing the uptake of sophisticated surgical devices.

The rising demand for minimally invasive surgical procedures is also contributing significantly to the growth of the ophthalmology cataract surgery devices market. Minimally invasive surgeries offer numerous benefits, such as reduced recovery time, less postoperative discomfort, and lower risk of complications. These advantages are appealing to both patients and healthcare providers, thus encouraging the adoption of advanced cataract surgery devices. Moreover, the increasing availability of these procedures in outpatient settings such as ambulatory surgery centers and ophthalmic clinics makes cataract surgeries more accessible and affordable for a larger population, further augmenting market expansion.

The introduction of the Phacoemulsifier has been a game-changer in cataract surgery, offering a more efficient and less invasive method for lens removal. This device uses ultrasonic vibrations to emulsify the lens, which is then aspirated out of the eye. The precision and control provided by the phacoemulsifier have significantly reduced the risks associated with cataract surgery, such as corneal damage and postoperative complications. Its ability to perform surgery through a smaller incision not only speeds up recovery time but also enhances the overall patient experience. As technology continues to evolve, phacoemulsifiers are becoming more sophisticated, incorporating features like improved fluidics and energy modulation, which further refine surgical outcomes and patient safety.

Regionally, North America holds a prominent position in the ophthalmology cataract surgery devices market owing to its well-developed healthcare infrastructure, high awareness levels among the population, and the presence of leading market players. Europe follows closely, with a significant market share driven by favorable government initiatives and an increasing focus on healthcare quality. The Asia Pacific region, however, is anticipated to witness the highest growth rate during the forecast period due to its large aging population, improving healthcare infrastructure, and rising disposable incomes. The demand in emerging economies such as China and India is expected to surge as these countries continue to invest in healthcare advancements and address the unmet needs in ophthalmic care.

Product Type Analysis

The product type segment in the ophthalmology cataract surgery dev

Global Ophthalmic Devices market size is expected to reach $70.64 billion by 2029 at 8.1%, the impact of increasing incidence and prevalence of eye diseases on the ophthalmic devices market

The Single Use Ophthalmic Surgical Devices Market size is expected to reach a valuation of USD 12.32 billion in 2033 growing at a CAGR of 5.50%. The Single Use Ophthalmic Surgical Devices Market research report classifies Market by share, trend, demand, forecast and based on segmentation.

The Single Use Ophthalmic Surgical Devices Market size was valued at USD 5.8 billion in 2023 and is projected to reach USD 9.01 billion by 2032, exhibiting a CAGR of 6.5 % during the forecasts period. The global single use ophthalmic surgical devices market relates to the instruments or tools designed for ophthalmic surgical procedures that are disposed of immediately after one use to eliminate the probability of transmitting infection. Surgical tools are those tools that are used in a sterile environment carrying out procedures that call for accuracy and precision such as cataract surgery, and vitrectomy, corneal transplantation. Examples include surgeons’ safety, speed, and patients’ health, boosted by the absence of sterilization and guaranteed dependability per operation. This has many applications and includes ophthalmology clinics, hospitals, and other ambulatory surgical centers. Market trends include innovation of technology that deals with material science in increasing the likelihood of the device in operating as a tool for biopsy as well as being bio-compatible, integration of micro-invasive as well as minimally invasive surgeries to the surgical instruments market, and attention of the government in improving safety and quality of single-use surgical instrument in ophthalmology surgery.

The size of the China Ophthalmic Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 4.50% during the forecast period. The Chinese ophthalmic devices market is a growing sector that is primarily driven by the increasing awareness of eye health, increasing population age, and rising technological inputs. Ophthalmic devices are the medical instruments or equipment used in diagnosing, treating, and managing many eye conditions. These devices include a broad range of products, such as intraocular lenses (IOLs), contact lenses, surgical instruments, diagnostic equipment, and laser systems. IOLs are actually implanted during cataract surgery so that the cloudy lens is replaced by a clear artificial one to regain vision. Contact lenses can correct refractive errors including myopia, hypermetropia, and astigmatism, presenting an option other than eyeglasses. Surgical instruments are necessary for performing surgeries in the eyes like cataract removal, treatment of glaucoma, and repair of retinal detachment. Diagnostic tools comprise an ophthalmoscope, a tonometer, and visual acuity chart to evaluate the general health of the eye as well as any anomalies. The laser systems are involved in many types of eye surgery- laser eye correction, glaucoma treatment and retinal surgery. The Chinese ophthalmic devices market is experiencing tremendous growth due to several reasons. The need for preventive care and treatment has become much more aware of, thus boosting the demand for products related to eye health. The population aged 60 years or above, which usually faces an increased risk of suffering from diseases such as cataract and glaucoma, is another reason for expansion in the market. Additionally, technological advances also influence the invention of better and efficient ophthalmic appliances, thus powering higher growth in the market. Recent developments include: June 2022: Samsara Vision teamed up with Lansheng Medical "MyVision," a China-based ophthalmology company, to create a comprehensive clinical and commercial organization to support Samsara Vision's SING IMTTM (Smaller-Incision New-Generation Implantable Miniature Telescope) in mainland China, Macau, the Hainan Province, and Hong Kong., June 2022: The National Medical Products Administration in China granted Iridex Corporation permission to market and sell its Cyclo G6 platform for the treatment of glaucoma illnesses (NMPA). According to the clearance, Iridex and distribution partners Topcon and Clinico will begin selling the Cyclo G6 system and accompanying probes in China in the third quarter of 2022.. Key drivers for this market are: Increasing Prevalence of Eye Diseases, Technological Advancements in Ophthalmic Devices. Potential restraints include: Risk Associated with Ophthalmic Procedures. Notable trends are: Glaucoma Devices Segment is Expected to Show Better Growth over the Forecast Period.

United Kingdom Ophthalmology Devices Market was valued at USD 1.1 Billion in 2023 and is projected to reach USD 1.5 Billion by 2031, growing at a CAGR of 4.5% from 2024 to 2031.

United Kingdom Ophthalmology Devices Market: Definition/ Overview

Ophthalmology devices are medical instruments and technologies used for the diagnosis, treatment, and management of various eye conditions and diseases. These devices include surgical instruments (like lasers and cataract surgery tools), diagnostic tools (like OCT machines and tonometer’s), and therapeutic devices (like intraocular lenses and contact lenses). Hospitals, eye clinics, and outpatient centers are just a few of the healthcare facilities that use them. The rising incidence of eye conditions like cataracts, age-related macular degeneration, and diabetic retinopathy, along with technological developments for more precise diagnosis and less invasive treatments, are driving growth in the UK market for ophthalmology devices. The need for ophthalmology devices is also fueled by an aging population, increased knowledge of eye health, and the desire for better healthcare results.

The global ophthalmic devices market is experiencing robust growth, driven by a rising aging population, increasing prevalence of age-related eye diseases like cataracts and glaucoma, and technological advancements leading to minimally invasive and effective surgical procedures. The market, currently estimated at $50 billion in 2025, is projected to reach approximately $75 billion by 2033, exhibiting a Compound Annual Growth Rate (CAGR) of approximately 6%. This growth is fueled by several factors including the increasing adoption of advanced diagnostic and monitoring devices enabling early detection and improved treatment outcomes. Furthermore, the rising disposable incomes in emerging economies are contributing to increased healthcare spending, further boosting market expansion. The segment dominated by diagnostic and monitoring devices is experiencing significant growth due to the increasing demand for early detection and improved patient care. However, the high cost of advanced devices and procedures, particularly in the refractive surgical devices segment, can restrain market growth in certain regions, particularly low and middle-income countries. Growth is expected to be particularly strong in North America and Europe due to established healthcare infrastructure and high adoption rates of advanced technologies. However, significant opportunities exist in rapidly developing economies in Asia Pacific and the Middle East & Africa, where increasing awareness and improving healthcare access are driving market penetration. Key players, including Essilor, Alcon, Johnson & Johnson, Bausch + Lomb, and others, are investing heavily in R&D and strategic partnerships to strengthen their market positions and expand their product portfolios. Competitive landscape remains intense, with companies focusing on innovation and product differentiation to gain a competitive edge. The market is segmented by application (hospital, specialty clinics, ambulatory surgical centers, etc.), and device type (diagnostic and monitoring, cataract surgical devices, etc.), providing granular insights into market dynamics and opportunities within specific segments.